Showing results (1-10 of 26) with videos related to
Sort By:
Pageof 3
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|August 30, 2024
Long noncoding RNAs as potential targets for overcoming chemoresistance in upper gastrointestinal cancersMostafa Vaghari-Tabari, Durdi Qujeq, Mohammad Sadegh HashemzadehDiabetes & Metabolic Syndrome|May 12, 2018
Direct correlation between serum homocysteine level and insulin resistance index in patients with subclinical hypothyroidism: Does subclinical hypothyroidism increase the risk of diabetes and cardio vascular disease together?Anahita Ebrahimpour, Mostafa Vaghari-Tabari, Durdi Qujeq, et al.Allergy and Asthma Proceedings|March 4, 2020
Association of serum 25-OH vitamin D₃ with serum IgE and the Pediatric Asthma Severity Score in patients with pediatric asthmaIraj Mohammadzadeh, Sorena Darvish, Durdi Qujeq, et al.Biological Trace Element Research|August 28, 2023
Zinc Oxide Nanoparticles and Cancer Chemotherapy: Helpful Tools for Enhancing Chemo-sensitivity and Reducing Side Effects?Mostafa Vaghari-Tabari, Davoud Jafari-Gharabaghlou, Mozafar Mohammadi, et al.The American Journal of the Medical Sciences|May 14, 2018
Positive Correlation of Fecal Calprotectin With Serum Antioxidant Enzymes in Patients With Inflammatory Bowel Disease: Accidental Numerical Correlation or a New Finding?Mostafa Vaghari-Tabari, Soheila Moein, Durdi Qujeq, et al.Caspian Journal of Internal Medicine|September 22, 2017
Diagnostic accuracy of fecal calprotectin in assessing the severity of inflammatory bowel disease: From laboratory to clinicSoheila Moein, Durdi Qujeq, Mostafa Vaghari Tabari, et al.African Journal of Laboratory Medicine|January 4, 2021
Sensitivity and specificity of mean platelet volume as a laboratory marker for irritable bowel syndrome: Can it be added to Rome criteria?Mostafa Vaghari-Tabari, Soheila Moein, Durdi Qujeq, et al.IUBMB Life|April 29, 2020
CRISPR/Cas9 gene editing: A new therapeutic approach in the treatment of infection and autoimmunityIraj Mohammadzadeh, Durdi Qujeq, Tooba Yousefi, et al.Biochemical Pharmacology|May 19, 2022
MicroRNAs and osteosarcoma: Potential targets for inhibiting metastasis and increasing chemosensitivityNegin Soghli, Gordon A Ferns, Fatemeh Sadeghsoltani, et al.Journal of Cellular Physiology|November 13, 2018
MiRNAs and inflammatory bowel disease: An interesting new storySoheila Moein, Mostafa Vaghari-Tabari, Durdi Qujeq, et al.Pageof 3